Trial Profile
A dose escalation, Pharmacokinetic study of DRGT-99.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Aug 2021
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary)
- Indications Erectile dysfunction
- Focus Adverse reactions; Pharmacokinetics
- 11 May 2018 New trial record
- 02 May 2018 Results presented in the Druggability Technologies media release.